Acute pancreatic beta cell apoptosis by IL-1β is responsible for postburn hyperglycemia: Evidence from humans and mice.

[1]  Xing Zhang,et al.  Dataset on acute hyperglycemia in extensively burned patients and mice , 2018, Data in Brief.

[2]  F. Gao,et al.  Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats. , 2018, American journal of physiology. Heart and circulatory physiology.

[3]  Jun Ren,et al.  Targeting autophagy in obesity: from pathophysiology to management , 2018, Nature Reviews Endocrinology.

[4]  A. I. Triggiani,et al.  Stress Profile in Remotely Piloted Aircraft Crewmembers During 2 h Operating Mission , 2018, Front. Physiol..

[5]  F. Gao,et al.  Short-Duration Swimming Exercise after Myocardial Infarction Attenuates Cardiac Dysfunction and Regulates Mitochondrial Quality Control in Aged Mice , 2018, Oxidative medicine and cellular longevity.

[6]  M. Jeschke,et al.  Glucose Control in Severely Burned Patients Using Metformin: An Interim Safety and Efficacy Analysis of a Phase II Randomized Controlled Trial , 2016, Annals of surgery.

[7]  A. Jaggi,et al.  Preclinical experimental stress studies: protocols, assessment and comparison. , 2015, European journal of pharmacology.

[8]  F. Pattou,et al.  Angiotensin II Induces Interleukin-1β–Mediated Islet Inflammation and β-Cell Dysfunction Independently of Vasoconstrictive Effects , 2014, Diabetes.

[9]  F. Gao,et al.  Acute Insulin Resistance Mediated by Advanced Glycation Endproducts in Severely Burned Rats , 2014, Critical care medicine.

[10]  D. Herndon,et al.  Survivors Versus Nonsurvivors Postburn: Differences in Inflammatory and Hypermetabolic Trajectories , 2014, Annals of surgery.

[11]  D. Andersen,et al.  The Glucoregulatory Benefits of Glucagon-Like Peptide-1 (7-36) Amide Infusion During Intensive Insulin Therapy in Critically Ill Surgical Patients: A Pilot Study , 2014, Critical care medicine.

[12]  J. Moon,et al.  Predicting Mortality of Critically Ill Patients by Blood Glucose Levels , 2013, Diabetes & metabolism journal.

[13]  D. Greenhalgh,et al.  Estimating severity of burn in children: Pediatric Risk of Mortality (PRISM) score versus Abbreviated Burn Severity Index (ABSI). , 2013, Burns : journal of the International Society for Burn Injuries.

[14]  M. Donath,et al.  Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. , 2013, Cell metabolism.

[15]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[16]  C. Murphy,et al.  Early Glycemic Control in Critically Ill Patients With Burn Injury , 2011, Journal of burn care & research : official publication of the American Burn Association.

[17]  P. Libby,et al.  Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). , 2011, American heart journal.

[18]  S. Fagan,et al.  Effects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury--studies in an animal model. , 2011, Surgery.

[19]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[20]  L. Evers,et al.  The biology of burn injury , 2010, Experimental dermatology.

[21]  D. Herndon,et al.  Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. , 2010, American journal of respiratory and critical care medicine.

[22]  L. Dai,et al.  A protocol for islet isolation from mouse pancreas , 2009, Nature Protocols.

[23]  J. L. Messina,et al.  Acute insulin resistance following injury , 2009, Trends in Endocrinology & Metabolism.

[24]  H. Ellingsgaard,et al.  Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction , 2009, Archives of physiology and biochemistry.

[25]  G. Taubes.  Insulin resistance. Prosperity's plague. , 2009, Science.

[26]  J. Preiser,et al.  Stress hyperglycaemia , 2009, The Lancet.

[27]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[28]  Silvio E. Inzucchi,et al.  Management of Hyperglycemia in the Hospital Setting , 2006 .

[29]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[30]  D. Herndon,et al.  CYTOKINE EXPRESSION PROFILE OVER TIME IN SEVERELY BURNED PEDIATRIC PATIENTS , 2006, Shock.

[31]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[32]  J. Corbett,et al.  Interleukin-1 Stimulates β-Cell Necrosis and Release of the Immunological Adjuvant HMGB1 , 2005, PLoS Medicine.

[33]  J. Rosenstock,et al.  Counterpoint: Inpatient glucose management: a premature call to arms? , 2005, Diabetes care.

[34]  H. Joller-jemelka,et al.  Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[35]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[36]  J. Nerup,et al.  Pancreatic beta‐cell function and interleukin‐1β in plasma during the acute phase response in patients with major burn injuries , 1993, European journal of clinical investigation.

[37]  R. Muniyappa,et al.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. , 2008, American journal of physiology. Endocrinology and metabolism.

[38]  H. Joller-jemelka,et al.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.